Doctor‑led 24x7 monitoring launches in Chennai

- A doctor‑led AI platform offering 24x7 remote patient monitoring outside hospital settings launched in Chennai. - Reports say the service provides real‑time supervision and plans expansion across southern India. - The launch ties continuous remote supervision to preventive care and clinician‑extender workflows, indicating an operational deployment model. (thehindubusinessline.com)

A doctor-led remote monitoring platform called iLive Connect was launched in Chennai on April 19 to track patients outside hospitals around the clock. (thehindubusinessline.com) The system uses a wireless biosensor patch and a wearable wristband to monitor heart activity, blood pressure trends and other vital signs in real time. Data goes to a remote command centre staffed 24x7 by doctors, who alert patients and families if they detect an abnormality. (business-standard.com) Remote patient monitoring is a way to keep watching a patient after discharge or between clinic visits, instead of waiting for symptoms to worsen at home. iLive Connect says its software looks for small physiological changes before they turn into emergencies that require rehospitalisation. (thehindubusinessline.com) The Chennai rollout is part of a wider southern India expansion. Founder Dr Rahul Chandola said the platform would be launched gradually in the remaining southern states after Chennai. (thehindubusinessline.com) The company is pitching the service at chronic patients and people at risk of sudden cardiac events, not as a general wellness gadget. Chandola said India sees nearly 8,000 deaths a day from heart disease and about 10,000 to 15,000 heart attacks daily, with 3,000 to 5,000 proving fatal. (business-standard.com) iLive Connect first surfaced nationally in February 2026, when the company said the platform had been introduced in New Delhi. At that time, it said a 10-week observational programme covering more than 410 patients found a 76% reduction in repeat hospitalisation. (thehindubusinessline.com) That 76% figure comes from company-reported observational data, not a published randomized trial. The available reports do not describe a peer-reviewed study or provide a comparison method beyond saying risks were identified earlier in monitored patients. (thehindubusinessline.com) The company has also said the wearable device is approved by the U.S. Food and Drug Administration and carries a CE mark, and that doctors at its command centre can contact patients within two minutes of a potentially harmful change. Those claims were reported when the platform launched nationally in February. (aninews.in) About 40 doctors attended the Chennai launch, including clinicians from Venkateswara Hospitals, MGM Healthcare, Prashanth Group of Hospitals and Kavery Hospital. The rollout puts a hospital-style monitoring workflow into homes, with Chennai now serving as the next operating base after the February debut. (business-standard.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.